Donald Trump brings U.S. drugs into cheapest prices abroad: Bill Ackman says “must like my thoughts”

U.S. President Donald Trump proposed on May 12 to cut the country’s prescription drug costs by dragging domestic prices to the lowest levels the company offers in the international market.

In a lengthy post on his social media platform Truth Social, Donald Trump said he will sign the effect at 9 a.m. (6.30 p.m.) in Washington on May 12. The gambit, who supports Donald Trump, is billionaire Bill Ackman, who said his proposal in March must have been liked by the president.

Donald Trump “must like my idea”

“President Donald Trump must like my idea,” Ackman posted on X, citing his March post, suggesting linking U.S. drug prices with international tax rates.

“The best way to lower the price of U.S. drugs is to make pharmaceutical companies sell the same foreign drugs at a price lower than what they sell, which will force them to sell here for the price. This will force global negotiations to be lower than what American consumers are now, rather than now, foreigners pay more than anyone paying for the company now. It has the expected effect.”

Today, the billionaire added that the United States has subsidized the world and praised Donald Trump as “the first president in history to correct the situation.” “The United States has subsidized the world in terms of trade, defense, drugs, NGOs, and more. Our global subsidies contribute to our $37 trillion in national debt. President Donald Trump is the first president in history to correct this situation. He deserves credit for that.”

It is worth noting that Bill Ackman, a supporter of Donald Trump, publicly criticized the U.S. president’s tariff policy.

We want to limit drug prices: What does Donald Trump say?

“For years, the world has been wondering why prescription drugs and medicines in the United States are much more expensive than other countries, sometimes five to ten times more expensive than the same drug made by the same company in the same lab or plant, and the same company in the same company?

He added: “Pharma/pharmaceutical companies will say that for years it was R&D costs, all of which are, and, anyway, all of which will be, and, anyway, will be, anyway, will be borne by the “fool” of the United States. At 9:00 am, I will sign one of the most important execution orders in my history.”

Donald Trump, who detailed the goals of his plan, noted that he expects prescription drugs and drugs to “reduce prices 30-80% immediately” and to rise in other countries to “will be fair for the United States.”

“I will have a most favored national policy through which the United States will pay the same price as the lowest price in the world. Our country will eventually be treated fairly and our citizens’ health care costs will no longer be reduced as previously thought. Moreover, among all the other things, the United States is most important to provide you with that,” he said.

Donald Trump’s drug price Gambit Tank Pharma stock

Bloomberg reported that the pharmaceutical company’s shares fell across Europe and Asia after Donald Trump’s position.

• In Europe, obesity maker Novo Nordisk A/S fell 8.6% during opening hours, the steepest shedder in the STOXX 600 health care index, which fell 3.3%.
• In Japan, pharmaceutical companies performed the worst, delaying the benchmark Topix. Chugai Pharmaceutical Co. fell 10% (the biggest dip since February 2024), Daiichi Sankyo Co. fell 7.8%, while Takeda Pharmaceutical Co. lost more than 5%.
• In Hong Kong, Beijinge Ltd fell 8.8%, and Innovent Biologics Inc. fell 6.4%.
• In South Korea, SK Biopharmaceuticals Co., Celltrion Inc. and Samsung Biologics Co. fell more than 3%.
• In India, Sun Pharmaceutical Industries Ltd. lost 7% at some point, while Lupine Ltd. and Aurobindo Pharma Ltd. fell by about 3%.

(with Bloomberg input)